Center for Technological Development in Health
In 2002, the U.K. Commission on Intellectual Property Rights suggested the creation of a network of public-private partnerships in the developing world that would mobilize the research resources of public sector institutions while taking advantage of the private sector’s ability to build research capacity. The goal of the Center for Technological Development in Health (CDTS) at the Oswaldo Cruz Foundation (Fiocruz) is to fuse individual research projects with industrial production partners in the private sector. Fiocruz includes laboratories for the development of specific products with product development partners and industrial/commercial partners. In 2007, the Center for Technological Development in Health signed an agreement with the biotechnology company Genzyme for R&D of drugs for 17 neglected diseases.
Carlos Morel, Fiocruz
Morel, Carlos M. et al. Health Innovation Networks to Help Developing Countries Address Neglected Diseases; Science Vol. 309 (15 July 2005): 401-404. Available here.
Morel, Carlos M., José R. Carvalheiro, Carmen N. P. Romero, Eduardo A. Costa and Paulo M. Buss. “The Road to Recovery. Nature Vol. 449 (13 September 2007): 180-182.
Morel, Carlos M.; The Center for Technological Development in Health (CDTS): Presentation to the Commission on Intellectual Property Rights, Innovation and Public Health (CIPIH). Presentation from Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil, 2 February 2005. Available here.
| Preview | Attachment | Size |
|---|---|---|
| CTDH Fiocruz.pdf | 2.53 MB |